Insider trade

Johnson & Johnson (JNJ): Director received 185.53 units

Eugene A. Woods, Director at Johnson & Johnson, reported a grant / award of 185.53 units.

185.53
Derivative units · @ $202.12
Traded
Dec 9, 2025
Filed
Dec 11, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 23, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  2. Oct 10, 2025Congress · 1 personMembers of Congress: 2 sales
  3. Oct 14, 2025Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
  4. Oct 16, 2025Federal contract · $384K obligatedDepartment of Defense awarded Johnson & Johnson: $384K obligated to date
  5. Oct 17, 2025InsiderOfficer sold ~$4.19M of JNJ shares in the open market
  6. Oct 30, 2025Congress · 1 personMembers of Congress: 1 purchase, 1 sale
  7. Oct 31, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  8. Nov 5, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  9. Nov 13, 2025CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
  10. Nov 20, 2025CongressDisclosed partial sale of JNJ — reported range $15,001 - $50,000
  11. Nov 26, 2025Insider · Their first buy on recordDirector purchased ~$258K of JNJ shares in the open market
  12. Dec 9, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000

What came next

  1. Dec 10, 2025Federal contract · $8K obligatedDepartment of Defense awarded Johnson & Johnson: $7.7K obligated to date
  2. Dec 18, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  3. Jan 21, 2026Company filing · Form 8-K · ResultsReported its results
  4. Jan 23, 2026CongressDisclosed partial sale of JNJ — reported range $15,001 - $50,000
  5. Jan 26, 2026Insider · 1 personInsiders: 2 sales (~$22.1M)
  6. Feb 5, 20265% stakeThe Vanguard Group reported a passive stake (13G) of 10.1%
  7. Feb 11, 2026Federal contract · $280K obligatedDepartment of Defense awarded Johnson & Johnson: $280K obligated to date
  8. Feb 13, 2026Insider · 1 personInsiders: 2 sales (~$10.1M)
  9. Feb 17, 2026Insider · 4 peopleInsiders: 9 sales (~$41.4M)
  10. Feb 18, 2026Insider · 1 personInsiders: 2 sales (~$5.5M)
  11. Feb 20, 2026InsiderChair sold ~$325K of JNJ shares in the open market
  12. Feb 27, 2026InsiderOfficer sold ~$1.01M of JNJ shares in the open market
  13. Mar 9, 2026FDAFDA device clearance: DePuy Synthes VOLT™ Proximal Tibia 3.5 Plating System
  14. Mar 10, 2026FDAFDA device clearance: DePuy Synthes VOLT™ Medial Distal Femur 3.5 Plating System
  15. Mar 10, 2026CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  16. Mar 11, 2026FDAFDA device clearance: INHANCE™ Reverse Shoulder System
  17. Mar 17, 2026FDAFDA drug approval: Icotyde
  18. Mar 19, 2026Congress · 1 personMembers of Congress: 2 sales
  19. Mar 20, 2026Federal contract · $20K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $20K obligated to date
  20. Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Johnson & Johnson

For Johnson & Johnson, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports, 4 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.

How this filing works

Explore the data

Common questions

Which Johnson & Johnson (JNJ) insider traded, and how much?

Eugene A. Woods, Director at Johnson & Johnson, reported a grant / award of 185.53 units. At $202.12.

When did it happen, and when was it made public?

Traded: Dec 9, 2025. Filed: Dec 11, 2025. That is 2 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Johnson & Johnson recently?

For Johnson & Johnson, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports, 4 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days. They are listed on the JNJ page.

Does this mean JNJ stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Johnson & Johnson

Everything OQRO holds on this company is on its JNJ page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data